BOSTON (Reuters) - GlaxoSmithKline’s experimental drug mepolizumab may help a small group of asthma sufferers whose illness can be difficult to control, researchers said on Wednesday.
BOSTON (Reuters) - GlaxoSmithKline’s experimental drug mepolizumab may help a small group of asthma sufferers whose illness can be difficult to control, researchers said on Wednesday.